Wonbiogen Co., Ltd. (KOSDAQ:307280)

Market Cap	49.58B +21.0%
Revenue (ttm)	34.38B +17.3%
Net Income	6.62B +22.9%
EPS	930.43 +31.4%
Shares Out	7.09M
PE Ratio	7.51
Forward PE	n/a
Dividend	140.00 (2.01%)
Ex-Dividend Date	Dec 29, 2025

Volume	11,332
Average Volume	58,142
Open	6,970.00
Previous Close	6,970.00
Day's Range	6,830.00 - 7,000.00
52-Week Range	4,765.00 - 8,400.00
Beta	0.68
RSI	42.88
Earnings Date	Mar 20, 2026

About Wonbiogen

Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co., Ltd. was founded in 2006 and is headquartered in Gumi-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2006
• Employees: 77
• Stock Exchange: KOSDAQ
• Ticker Symbol: 307280

Financial Performance

In 2024, Wonbiogen's revenue was 30.44 billion, an increase of 2.79% compared to the previous year's 29.61 billion. Earnings were 5.69 billion, an increase of 3.50%.